Member LoginDividend CushionValue Trap |
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for
any changes.
Apr 4, 2025
Dividend Increases/Decreases for the Week of April 4
Let's take a look at firms raising/lowering their dividends this week. Mar 17, 2025
Realty Income Has Raised Its Dividend 130 Times Since Listing on the NYSE in 1994
Image Source: Realty Income. In March 2025, Realty Income announced its 130th dividend increase since it listed on the NYSE in 1994. The annualized dividend amount now stands at $3.222 per share compared to the prior annualized dividend amount of $3.216 per share. Looking to 2025, Realty Income’s net income per share is expected between $1.52-$1.58, AFFO per share is targeted at $4.22-$4.28, while same store rent growth is expected to be approximately 1% on occupancy over 98%. As of December 31, 2024, the REIT had $3.7 billion of liquidity. We like Realty Income but don’t include shares of the REIT in any newsletter portfolio. Shares yield 5.7% at the time of this writing. Mar 9, 2025
Costco Is Not Immune to Tariff Pressures
Image Source: Costco. For the 24 weeks ended February 16, 2025, Costco’s net cash provided by operating activities increased to $6.0 billion from $5.4 billion in the same period a year ago. Additions to property and equipment came in at $2.4 billion for the 24 weeks ended February 16, 2025, up from $2.1 billion in last year’s quarter. Free cash flow was $3.6 billion over the 24 weeks. Cash and cash equivalents increased to $12.36 billion, higher than its long-term debt load of $5.76 billion. We like Costco, but its shares are mighty pricey, and tariffs may create short-term disruptions as the firm works to deal with the expected higher costs through its supply chain. Mar 7, 2025
Dividend Increases/Decreases for the Week of March 7
Let's take a look at firms raising/lowering their dividends this week. Feb 28, 2025
Dividend Increases/Decreases for the Week of February 28
Let's take a look at firms raising/lowering their dividends this week. Feb 25, 2025
Domino’s Remains a Key Idea in the Best Ideas Newsletter Portfolio
Image: Domino’s shares have advanced nicely since the beginning of 2023. For fiscal 2024, net cash provided by operating activities increased 5.8% on a year-over-year basis, while capital expenditures expanded 7.1%, resulting in free cash flow growth of 5.5%, to $512 million. The company experienced global net store growth of 775 for fiscal 2024, and we continue to like Domino’s future growth prospects. During the fourth quarter, the company repurchased a total of $112 million in stock, and as of December 29, had total remaining buyback authorization of $814.3 million. We like Domino’s long-term picture and include the firm as a holding in the Best Ideas Newsletter portfolio. Feb 21, 2025
Walmart’s Earnings Outlook Falls Short of Expectations
Image Source: Walmart. Walmart ended its fiscal year with cash and cash equivalents of $9.0 billion and total debt of $45.8 billion. Operating cash flow for fiscal 2025 was $36.4 billion, an increase of $0.7 billion from last year, while free cash flow remained robust at $12.7 billion. Looking to the first quarter of fiscal 2026, net sales are expected to increase 3%-4%, while adjusted operating income is expected to advance 0.5%-2%, with adjusted earnings per share targeted in the range of $0.57-$0.58, below the $0.65 consensus estimate. For all of fiscal 2026, net sales are anticipated to increase 3%-4%, with adjusted operating income expected to increase 3.5%-5.5%. Adjusted earnings per share is targeted in the range of $2.50-$2.60 for the full year (consensus was at $2.76), inclusive of a $0.05 headwind from currency. Shares yield 0.9%. Feb 21, 2025
Dividend Increases/Decreases for the Week of February 21
Let's take a look at firms raising/lowering their dividends this week. Feb 11, 2025
Vertex Pharma Is One of Our Favorite Biotechs
Image: Vertex Pharma has performed quite well since the beginning of 2023. Looking to 2025, Vertex expects total revenue of $11.75-$12 billion, which includes expectations for continued growth in its cystic fibrosis portfolio, “including the U.S. launch of ALYFTREK, as well as continued uptake of CASGEVY in multiple regions; and early contributions from the launch of JOURNAVX." Cash and total marketable securities as of the end of last year were $11.2 billion, compared to $13.7 billion at the end of 2023 due to the cash consideration paid to acquire Alpine and share buybacks. Vertex had no traditional debt. We continue to like Vertex Pharma as a holding in the Best Ideas Newsletter portfolio. Feb 6, 2025
Chipotle's Long-term Growth Prospects Are Impressive
Image Source: Valuentum. During the fourth quarter of 2024, Chipotle bought back ~$330 million of stock, and as of the end of last year, the company had $1 billion remaining available under share repurchase authorizations. Looking to 2025, management expects full year comparable restaurant sales growth in the low to mid-single digit range and plans for 315-345 new company-owned restaurant openings with over 80% having a Chipotlane. At the end of 2024, Chipotle had 3,746 total restaurants, and the firm is targeting as many as 7,000 restaurants in North America alone. We like Chipotle’s long-term growth potential, and the firm remains a holding in the Best Ideas Newsletter portfolio.
prev12345678910111213141516171819202122232425
26272829303132333435363738394041424344454647484950 51525354555657585960616263646566676869707172737475 767778798081828384858687888990919293949596979899100 101102103104105106107108109110111112113114115116117118119120 121122123124125126127128129130131132133134135136137138139140 141142143144145146147148149150151152153154155156157158159160 161162163164165166167168169170171172173174175176177178179180 181182183184185186187188189190191192193194195196197198199200 next The High Yield Dividend Newsletter, Best Ideas
Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on
this website are for information purposes only and should not be considered a solicitation to buy or sell any
security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s
accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or
omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts
no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a
registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees,
and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.
|